Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Saflink Corp. (ESAF) Biometric Software Provider -- Ignore unavailable to you. Want to Upgrade?

To: bob jordan who wrote (4586)	1/9/2000 10:51:00 AM
From: David	Read Replies (1) \| Respond to of 4676

I'm looking for something to disagree with in your post, and this is all I could come up with: * Your typo of "BioCrap" when you intended to write, "BioLogon 2.0." Reminds me of that old joke about the woman who went to her shrink and discussed an amusing Freudian slip she had recently made. "I meant to say, 'please pass the salt, Mom' but it came out 'You ruined my life, you bitch.'" * I'm pretty sure that the way IDX is recognizing revenues on its IDT products eliminates the risk of a writedown at the cost of backloading revenue recognition. In other words, IDX sees very little revenue when the product enters the channel ("is shipped") in favor or recognizing almost all of it when it is sold to the end user. Last quarter was a bit too early for recognizing those revenues. We'll get a much better fix this time around.